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FentanylAbstract Background: Anesthesia for cochlear implantation in pediatrics mandates deliberate
hypotension to provide a better surgical field. Dexmedetomidine is a2 adrenoceptor agonist that
provides adequate sedation with high cardiovascular stability. We aimed to compare it with
fentanyl as an anesthetic adjuvant.
Methods: 52 pediatric patients (ASA I or II), undergoing cochlear implantation were randomized
into dexmedetomidine (D) group and fentanyl (F) group (n= 26 for each). Anesthesia was induced
by I.V. dexmedetomidine in (D) group at a bolus dose of 0.4 lg/kg slowly infused over 10 min, then
continuous infusion by a rate of 0.4 lg/kg/h until the end of surgery. In (F) group; anesthesia was
induced by I.V. fentanyl at a dose of 1 lg/kg over 10 min, then continuous infusion by a rate of
1 lg/kg/h. This is followed by I.V. propofol and atracurium for both groups. Maintenance was
done without additional muscle relaxant to allow monitoring of the facial nerve. Both groups were
compared as regards the quality of the surgical field, intraoperative hemodynamics, recovery and
discharge time, postoperative pain using objective pain score and the need for rescue analgesics
and anti-emetics in postanesthesia care unit (PACU).
Results: Dexmedetomidine group showed a decreased heart rate and mean arterial pressure than
fentanyl group. These parameters were significantly decreased compared to the baseline throughout
the procedure in D group. The quality of the surgical field was significantly better in D group than
in F group. Postoperative pain and complications were not different between the two groups.
Recovery and discharge time was significantly shorter for the patients in D group than in F group
(p< 0.05).
Conclusion: Dexmedetomidine infusion in cochlear implantation in pediatric patients was better in
inducing deliberate hypotension and providing better quality scale of surgical field compared to fen-
tanyl infusion. It allowed rapid recovery from anesthesia and reduced need for pain medication in
the PACU.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
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Surgery for cochlear implantation is a great advance in otology
for patients with irreversible hearing loss and deaf-mutism but
it carries a great challenge to the anesthesiologist [1].
Anesthetic management includes bloodless surgical field to
facilitate microsurgery, efficient airway management, careful
head positioning to avoid venous obstruction and congestion,
limited use of muscle relaxants to facilitate monitoring of
the facial nerve by peripheral nerve stimulator, smooth
recovery and adequate post-operative care without nausea
and vomiting [2].
Controlled hypotension can be achieved by a combination
of physical techniques and pharmacologic agents: inhalational
anesthetics, opioids, vasodilators, beta blockers, magnesium
sulfate and a2 adrenergic agonists [3,4].
Dexmedetomidine is an a2 adrenergic agonist with a seda-
tive and analgesic effect. It does not cause respiratory depres-
sion even at supramaximal plasma levels [5]. It suppresses
sympathetic activity and decreases airway and circulatory
responses during intubation and extubation [6]. Previous
reports recommended its use instead of fentanyl to augment
anesthesia [7,8].
According to the available data, no study had been pub-
lished to compare fentanyl and dexmedetomidine in pediatrics
undergoing cochlear implantation.
1.1. Aim of work
The main objective was to compare fentanyl with dexmedeto-
midine as regards their efficacy in inducing deliberate hypoten-
sion and providing better quality of the surgical field during
cochlear implantation. The effect of both drugs on postopera-
tive pain and recovery time was also compared.
2. Patients and methods
This study was a prospective, randomized, blind study that
conducted at Kasr El-Ainy hospital, Cairo University, from
April 2012 to March 2014 after approval of ethical committee.
Informed consents were obtained from parents or guardians of
all children.
Fifty-two pediatric patients of ASA physical status I or II,
aged below 8 years and scheduled for elective cochlear implan-
tation, were enrolled in this study. Patients with known allergy
to fentanyl or dexmedetomidine were excluded from the study.
Also, patients with fever, upper respiratory tract infection,
coagulopathy, prolonged QT interval and ventricular arrhyth-
mia were excluded. Also, patients with congenital abnormali-
ties were excluded. Randomization was accomplished by
using computerized randomization tables.
All patients were preoperatively assessed by history, physi-
cal examination and routine laboratory investigations (CBC,
PT, PTT, INR, urea, creatinine, SGPT, SGOT, albumin,
bilirubin and serum electrolytes). Cardiological consultation
and pre-operative ECG were done. Careful assessment of the
airway was done. Careful search for renal, endocrine abnor-
malities, goiter and hypothyroidism was done.
Solid food was not allowed 6 h before surgery but clear flu-
ids were given for up to 2 h pre-operatively. Children were ran-
domized into dexmedetomidine (D) group and fentanyl (F)group (n= 26 for each). Preparation of dexmedetomidine
(Precedex; Abbott Laboratories, North Chicago, Illinois,
USA) (vial = 2 ml) 100 lg/ml and fentanyl ampoule
100 lg/2 ml was done. Each drug was diluted with 48 ml
of 0.9% NaCl in 50 ml syringe to get a concentration of
4 lg/ml in dexmedetomidine group and 2 lg /ml in fentanyl
group.
Demographic data were recorded including age, sex and
weight.
On arrival to the operating room; an intravenous catheter
was inserted. Monitors were applied: precordial stethoscope,
noninvasive automatic blood pressure, pulse oximeter and elec-
trocardiograph. Peripheral nerve stimulator was used to assess
recovery from muscle relaxant and to monitor the facial nerve
intra-operatively. Premedication with 0.15 mg/kg I.V. dexam-
ethasone was done to prevent postoperative nausea and vomit-
ing. Induction of anesthesia was done by I.V. dexmedetomidine
in (D) group at a bolus dose of 0.4 lg /kg slowly infused over
10 min, then continuous infusion by a rate of 0.4 lg/kg/h. until
the end of surgery. In (F) group; fentanyl was given at a dose of
1 lg/kg over 10 min, then continuous infusion by a rate of
1 lg/kg/h until the end of surgery. This is followed by propofol
2 mg/kg for both groups. Then, I.V. atracurium at a dose of
0.5 mg per kg was given to facilitate intubation. When T1 is
0%, the patient was intubated by a proper sized cuffed endotra-
cheal tube. Additional doses of atracurium were not adminis-
tered to allow intraoperative monitoring of the facial nerve.
Anesthesia was maintained using a mixture of O2 and air in
a ratio of 1:1 mixture with 2% sevoflurane. Controlled ventila-
tion at a tidal volume of 6 ml/kg was initiated to maintain nor-
mocapnia (35–40 mmHg) by adjusting the respiratory rate and
guided by the end tidal CO2 monitoring. Body core tempera-
ture was measured by oropharyngeal temperature probe and
maintained between 36 and 37 C using heated mattress and
warm intravenous fluids at room temperature. Anesthesia
was maintained with continuous infusion of the tested drugs.
The target blood pressure was a decrease in blood pressure
to get the mean blood pressure (MAP = 50–60 mmHg). If
the MAP increased above the target, a bolus dose of either
dexmedetomidine or fentanyl similar to the induction dose
was added. Bradycardia was treated with 0.02 mg/kg I.V. atro-
pine if the HR was 20% lower than the baseline value. Fluids
were given at 10 ml/kg/h in the form of dextrose 5% and nor-
mal saline at a ratio of 1:1. At the end of the procedure, the
patient was extubated under deep anesthesia to avoid coughing
(which may cause dislodgement of the electrode array of the
implant) and transferred to the recovery room.
2.1. Intra-operative data recorded
1. Heart rate (HR) and mean arterial blood pressure (MAP).
These data were recorded before induction (baseline), 1 min
after induction, 1 min after intubation then every 15 min till
the end of the operation.
2. Total dose of dexmedetomidine and fentanyl.
3. Total time of the operation.
4. Quality scale:
The surgeon who was blinded of the selected hypotensive
agent was asked to assess the quality of the surgical field
according to the quality scale proposed by Fromme and
colleagues [9]:
Table 1 Demographic data and operative time.
F-group (n= 26) D-group (n= 26) P-value
Age (years) 6.17 ± 1.67 5.91 ± 1.62 0.567
Weight (kg) 24.19 ± 5.32 22.23 ± 4.44 0.156
Sex:
M 11 (42.3%) 10 (38.5%)
F 15 (57.7%) 16 (61.5%) 0.500
Operative time (min) 117.88 ± 26.4 121.53 ± 25.6 0.615
Data expressed as mean (±SD) and number (% from total).
*Statistically significant (P value 6 0.05).
Dexmedetomidine versus fentanyl 570 = no bleeding.
1 = slight bleeding – blood evacuation not necessary.
2 = slight bleeding – sometimes blood has to be evacuated.
3 = low bleeding – blood has to be often evacuated. Oper-
ative field is visible for some seconds after evacuation.
4 = average bleeding – blood has to be often evacuated.
Operative field is visible only right after evacuation.
5 = high bleeding – constant blood evacuation is needed.
Sometimes, bleeding exceeds evacuation. Surgery is hardly
possible.
Postoperatively, both recovery time and discharge time
were recorded for all patients. Recovery time was defined as
the period of time from discontinuation of sevoflurane till
achieving a modified Aldrete recovery score of at least 9. Dis-
charge time was defined as the time from the end of the proce-
dure until the child fulfilled the discharge criteria from PACU.
The criteria of discharge were returning of vital signs and level
of consciousness to baseline, and ability to ambulatewithout help
and to tolerate clear fluids without nausea and vomiting.
Postprocedural recovery was evaluated using a modified
Aldrete score [10] at 10 min at the recovery room. Postproce-
dural pain was assessed every 10 min in the recovery room
using Objective Pain Scale (OPS) [11]. Diclofenac suppository
(12.5 or 25 mg) was given if OPS wasP4. It was given accord-
ing to the nearest dose guided by body weight (2 mg/kg).
Postoperative nausea and vomiting were monitored for
24 h. Intravenous ondansetron (0.1 mg per kg) was given if
nausea and vomiting had occurred. Number of patients who
suffered from apnea was recorded. The anesthetist who was
recording the intra-operative and postoperative data did not
share in preparing or giving the selected agent.
2.2. Sample size calculation
Based on two-tailed a error probability of 0.05 and b error
probability of 0.2 (power of 80%), a total sample size of 52
patients equally allocated into two groups was required to
detect a presumed minimum clinically significant decrease of
20% in intra-operative mean arterial blood pressure (effect size
d of 0.8). Statistical power calculations were performed using
computer program G*Power 3 for Windows (Franz Faul,
Universita¨t Kiel, Germany).
2.3. Statistical analysis
Obtained data were presented as mean ± SD, ranges, numbers
and percentages as appropriate. Nominal variables were ana-
lyzed using Chi-squared (v2) test or Fischer exact test as appro-
priate. Continuous variables were analyzed using unpaired
Student’s t-test or univariate two-group repeated measures
analysis of variance (ANOVA) with post hoc Dunnett’s test
as appropriate. Nominal and non-normally distributed vari-
ables were analyzed using Mann–Whitney U test. Statistical
analysis was performed using SPSS (Version 20, 2011).
P value < 0.05 was considered statistically significant.
3. Results
Fifty-two patients were enrolled (26 patients in each group)
and completed the study.– There was no statistically significant difference between
both groups regarding the patients’ demographic data and
operative time (Table 1).
– Intra-operative heart rate was statistically significantly
lower in D group than in F group at all time periods
(P< 0.05). In (D) group, there was a significant reduction
in heart rate values in comparison with the baseline value at
all time periods while in (F) group, the difference was not
significant (Fig. 1).
– Intra-operative mean blood pressure (MAP) was lower in D
group than in F group at all time periods. This decrease was
statistically significant at 1 min after intubation and at
60 min but no significant difference was observed between
both groups during the remaining time periods. The MAP
decreased significantly from the baseline value at all time
periods in (D) group while in (F) group the decrease in
MAP from the baseline was not significant during all time
periods except at 1 min after induction (Fig. 2).
– The quality of the surgical field intra-operatively was signif-
icantly better in dexmedetomidine group (Table 2).
– Total dose of the drug used intra-operatively was 78.28
± 22.05 lg for fentanyl and 26.22 ± 6.30 lg for dexmedeto-
midine. 2 patients in dexmedetomidine group required a
bolus dose (given once), while in fentanyl group 6 patients
required a bolus dose (given once).
– Regarding recovery and discharge time, dexmedetomidine
group showed significantly shorter recovery time [9.5
± 2.46] min versus [12.28 ± 3.47] min in F-group, and sig-
nificantly shorter discharge time [23.46 ± 4.29] min versus
[28.34 ± 5.78] min in F-group.
– There was no statistically significant difference between
both groups regarding the objective pain score (every
10 min from 10 to 40 min) (Fig.3). Two patients of D group
and seven patients of F group had required bolus doses of
rectal diclofenac at 10 min at PACU. It was given once.
– There was no statistically significant difference between
both groups regarding modified Aldrete score (Table 3),
and the need for anti-emetics in PACU (Five patients in
fentanyl group required anti-emetics versus two patients
in dexmedetomidine group). No cases of apnea were
reported in the study groups.
4. Discussion
Dexmedetomidine is a potent a2 adrenergic agonist with a
distribution half-life of 8 min and a terminal half-life of
3.5 h. Its short half-life provides easy titration, quick recovery
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Figure 1 Intra-operative heart rate in dexmedetomidine (D) and
fentanyl (F) groups. (*) denotes significance between both groups.
(y) denotes significance in the same group in comparison with the
baseline value. P value 6 0.05 (statistically significant).
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Figure 2 Intra-operative mean blood pressure (MAP) in
dexmedetomidine and fentanyl groups. (*) denotes significance
between both groups, and (y) denotes significance in the same
group compared to the baseline value. P value 6 0.05 (statistically
significant).
Table 2 Comparison between dexmedetomidine group and
fentanyl group as regards quality scale for surgical field intra-
operatively.
Fentanyl group
(n= 26)
Dexmedetomidine
group (n= 26)
P value
Quality scale 2.76 ± 0.76 2.19 ± 0.80 0.011*
* Statistically significant (P value 6 0.05).
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Figure 3 Comparison between fentanyl group and dexmedeto-
midine group as regards objective pain score.
Table 3 Comparison between fentanyl group and dexmedeto-
midine group as regards modified Aldrete score.
Fentanyl
group (n= 26)
Dexmedetomidine
group (n= 26)
P value
MAS (10 min) 9.11 ± 0.71 9.42 ± 0.50 0.078
MAS: Modified Aldrete Score at 10 min in PACU.
*Statistically significant (P 6 0.05).
58 M.H. El Saied et al.and less adverse events related to prolonged sedation. It pro-
vides adequate sedation with high cardiovascular and respira-
tory stability [12,13]. a2-adrenoceptors exist on the dorsal horn
neurons of the spinal cord and can release endogenous opiate
compounds. Thus, a2-adrenoceptor agonists may be used in
pain management and may decrease intra-operative opioid
requirements, similar to clonidine [14].
The main finding in this study was that dexmedetomidine
showed a significant reduction in intra-operative HR and
MAP more than fentanyl. However, the intra-operative reduc-
tion in hemodynamic parameters (MAP and HR) in both
groups was within 20% from baseline values. It also showed
that dexmedetomidine has significantly better surgical quality
scale, shorter recovery and discharge time than fentanyl.The use of dexmedetomidine in pediatric population is lim-
ited. Mason et al. [15] were the first who studied the sedative
effect of dexmedetomidine on pediatric patients for radiologi-
cal imaging studies. They reported that dexmedetomidine pro-
duced a reduction of HR and MAP which was clinically
acceptable for the pediatric age group. These findings coincide
with the results of the present study. On the other hand,
Koroglu et al. [13] noticed that dexmedetomidine produced a
reduction of HR only in comparison with propofol in children
undergoing MRI study.
In line with the current study, Tanskanen et al. [16]
reported that dexmedetomidine was an excellent anesthetic
adjuvant because of the perioperative hemodynamic stability
and the faster tracheal intubation that obtained in comparison
with fentanyl in patients undergoing brain surgery.
Also, Feld et al. [7] compared dexmedetomidine with fen-
tanyl in bariatric surgery. They reported that dexmedeto-
midine decreased sympathovagal balance and heart rate
intra-operatively more than fentanyl.
Bulow et al. [17] concluded that dexmedetomidine provided
better hemodynamic stability than remifentanil in patients
undergoing invasive video gynecologic surgical procedures.
They observed a prolonged recovery time in patients received
dexmedetomidine when compared with those received remifen-
tanil. Remifentanil has an elimination half-life of 7 min and
degradation is done by blood and tissue esterase. So, remifen-
tanil infusion does not cause overhanging effects and is much
shorter than fentanyl. This could explain their results.
Ali et al. [18] had compared dexmedetomidine with fentanyl
in pediatric patients undergoing extracorporeal shock wave
lithotripsy and reported that the MAP and HR were signifi-
cantly decreased compared to the baseline throughout the pro-
cedure in both groups. These results are consistent with the
present study.
Turgut et al. [19] reported that MAP values were signifi-
cantly higher in dexmedetomidine group than in fentanyl
group only after intubation, while they were significantly lower
Dexmedetomidine versus fentanyl 59in dexmedetomidine group than in fentanyl group before and
after extubation during lumbar laminectomy surgery. There
was no statistically significant difference in HR between
groups. In contrast to the present study, they noticed a compa-
rable recovery and discharge times when comparing fentanyl
and dexmedetomidine. This could be due to the smaller load-
ing and maintenance doses (fentanyl: 0.64 ± 0.06 lg/kg1 h,
dexmedetomidine 0.31 ± 0.08 lg/kg1 h) they have used.
This study found no significant difference between both
groups as regards postoperative nausea and vomiting, and
objective pain score. Also, dexmedetomidine decreased the
need for pain medication in the PACU.
In accordance with these findings, Feld et al. [7] reported
that dexmedetomidine provided stable postoperative analge-
sia, thus reducing the use of morphine in the postoperative per-
iod when comparing fentanyl and dexmedetomidine combined
with desflurane for bariatric surgery.
However, Ali et al. [18] reported significantly higher inci-
dence of nausea and vomiting in pediatric patients receiving
fentanyl in comparison with those receiving dexmedetomidine
during extracorporeal shock wave lithotripsy. Also, the same
results were reported by Turgut et al. [19] in adult patients
undergoing lumbar laminectomy.
As a limitation of this study, there was no control group in
which propofol was used alone, as it would be unethical; also a
subjective scoring system was used to evaluate the quality of
the surgical field and the lack of BIS monitor to assess depth
of anesthesia. Future studies are needed to compare the effi-
cacy of dexmedetomidine with other commonly used agents
during cochlear implantation in pediatrics.
5. Conclusion
Dexmedetomidine infusion in cochlear implantation in pedi-
atric patients was better in inducing deliberate hypotension
and providing better quality scale of surgical field compared
to fentanyl infusion. It allowed rapid recovery from anesthesia
and reduced need for pain medication in the PACU.
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